UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $53.73 Million Stake in Doximity, Inc. (NASDAQ:DOCS)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC trimmed its position in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 17.2% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,233,291 shares of the company's stock after selling 255,612 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.66% of Doximity worth $53,734,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. MetLife Investment Management LLC boosted its holdings in Doximity by 0.6% during the third quarter. MetLife Investment Management LLC now owns 65,064 shares of the company's stock worth $2,835,000 after buying an additional 363 shares in the last quarter. First Horizon Advisors Inc. grew its holdings in shares of Doximity by 22.5% in the 3rd quarter. First Horizon Advisors Inc. now owns 2,094 shares of the company's stock worth $91,000 after acquiring an additional 384 shares during the last quarter. GAMMA Investing LLC raised its position in shares of Doximity by 40.1% during the third quarter. GAMMA Investing LLC now owns 1,439 shares of the company's stock worth $63,000 after purchasing an additional 412 shares during the period. Van ECK Associates Corp lifted its holdings in shares of Doximity by 19.7% during the second quarter. Van ECK Associates Corp now owns 2,590 shares of the company's stock valued at $72,000 after purchasing an additional 427 shares during the last quarter. Finally, Cornercap Investment Counsel Inc. increased its stake in Doximity by 3.2% in the 2nd quarter. Cornercap Investment Counsel Inc. now owns 17,143 shares of the company's stock worth $479,000 after purchasing an additional 537 shares in the last quarter. 87.19% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have commented on DOCS. KeyCorp upgraded shares of Doximity from a "sector weight" rating to an "overweight" rating and set a $70.00 target price for the company in a report on Friday, November 8th. Truist Financial lifted their price objective on shares of Doximity from $35.00 to $49.00 and gave the stock a "hold" rating in a research report on Thursday, November 14th. The Goldman Sachs Group began coverage on Doximity in a report on Friday, November 15th. They issued a "neutral" rating and a $58.00 target price for the company. Morgan Stanley upgraded Doximity from an "underweight" rating to an "equal weight" rating and lifted their price target for the company from $33.00 to $53.00 in a report on Thursday, November 14th. Finally, Robert W. Baird upped their price target on Doximity from $41.00 to $45.00 and gave the company an "outperform" rating in a research report on Tuesday, September 17th. Twelve research analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Doximity currently has an average rating of "Hold" and an average target price of $52.44.

Doximity Trading Up 1.5 %

DOCS stock traded up $0.79 during midday trading on Wednesday, hitting $54.20. The stock had a trading volume of 1,264,673 shares, compared to its average volume of 1,757,519. The firm has a market capitalization of $10.12 billion, a price-to-earnings ratio of 62.30, a P/E/G ratio of 4.28 and a beta of 1.40. Doximity, Inc. has a 52 week low of $22.96 and a 52 week high of $61.75. The stock has a 50-day simple moving average of $46.10 and a 200 day simple moving average of $36.39.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.